Herpes Simplex Virus Infection
📧 Sign up to get email alerts when something new happens for Herpes Simplex Virus Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-01-29FDA Approved: ACYCLOVIR — Original Application (Xiromed, LLC)
FDA approved the original ANDA for acyclovir from Xiromed, LLC, providing a generic version of the antiviral for herpes simplex virus infect…
-
FDA approval · 2019-10-07FDA Approved: ACYCLOVIR — Original Application (Bionpharma Inc.)
FDA approved the original ANDA for acyclovir by Bionpharma Inc., authorizing a generic version.
-
FDA approval · 2019-03-29FDA Approved: AVACLYR — Original Application (Fera Pharmaceuticals, LLC)
The FDA approves AVACLYR (acyclovir) from Fera Pharmaceuticals via an original NDA for treatment of herpes simplex and varicella-zoster viru…
-
FDA approval · 2019-01-11FDA Approved: ACYCLOVIR — Original Application (Torrent Pharmaceuticals Limited)
FDA approves Torrent Pharmaceuticals Limited's generic acyclovir tablets through an original ANDA.
-
FDA approval · 2018-11-19FDA Approved: DOCOSANOL — Original Application (Care One (Retail Business Services, LLC.))
FDA approved an original application for docosanol by Care One, establishing a generic docosanol topical product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-08-31FDA Approved: ACYCLOVIR — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved the original application for acyclovir from Zydus Pharmaceuticals (USA) Inc., enabling a generic version of acyclovir.
-
CLINICAL_TRIALS trial_result · 2018-02-12Clinical Trial Update: VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies. [Phase 4]
Phase 4 trial updating viral shedding results for VALTREX (valacyclovir) in HSV-2 seropositive subjects; study completed with results posted…
-
CLINICAL_TRIALS trial_result · 2017-06-02Clinical Trial Update: Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive Adults [Phase 1]
Phase 1 safety evaluation of a glycoprotein D vaccine (gD vaccine) for herpes simplex virus in HSV-positive healthy adults, with and without…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood [NA]
A completed clinical trial evaluated whether acyclovir treatment of herpes simplex virus infection affects HIV levels in the blood.
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia [Phase 4]
Phase 4 trial evaluating valacyclovir augmentation for cognitive and functional remediation in schizophrenia has completed.
-
CLINICAL_TRIALS withdrawal · 2016-06-07Clinical Trial Update: A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease) [Phase 1, Phase 2]
A phase 1/2 trial evaluating CMX001 (brincidofovir) for safety and dose determination in infants with neonatal herpes simplex virus infectio…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2? [Phase 3]
A Phase 3 trial investigated whether valacyclovir can attenuate inflammation in people with HIV on antiretroviral therapy who are co-infecte…
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin
Completed retrospective chart review evaluating the antiviral supplement Gene-Eden-VIR/Novirin across multiple viral infections to assess ou…
-
FDA approval · 2016-04-14FDA Approved: XERESE — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for XERESE (acyclovir and hydrocortisone) from Bausch Health US LLC under NDA 022436. The approv…
-
FDA approval · 2016-02-29FDA Approved: ACYCLOVIR — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc. for an original application of acyclovir as a generic product, expanding generic options for acy…
-
CLINICAL_TRIALS trial_result · 2015-07-10Clinical Trial Update: A Two Arm, Multi-Site Clinical Evaluation of the ARIES HSV 1&2 Assay in Symptomatic Patients
This document reports a completed two-arm, multi-site clinical evaluation of the ARIES HSV 1&2 Assay in symptomatic patients.
-
CLINICAL_TRIALS research · 2015-05-22Clinical Trial Update: Review of Human Herpes Viruses in Burns
This completed clinical trial update reviews the involvement of human herpesviruses in burn injuries, focusing on herpes simplex virus, vari…
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection [Phase 3]
Phase 3 trial evaluating the safety and effectiveness of 1% tenofovir gel to prevent HIV-1 infection in women, and its effect on HSV-2 incid…
-
CLINICAL_TRIALS research · 2014-12-23Clinical Trial Update: Herpes Simplex Reactivation in Adult Critical Care Patients
This update covers a clinical trial on herpes simplex reactivation in adult critical care patients ( HSV-1 and HSV-2 ) with no current statu…
-
FDA approval · 2014-11-07FDA Approved: FOSCAVIR — Supplemental Application (Clinigen Limited)
The FDA approved a supplemental application for FOSCAVIR (foscarnet sodium) from Clinigen Limited, authorizing changes to the product labeli…
-
FDA approval · 2014-09-10FDA Approved: FAMCICLOVIR — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved a generic version of famciclovir under an original ANDA from Camber Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons [Phase 4]
Phase 4 trial comparing valacyclovir to acyclovir for suppression of herpes simplex virus type 2 in people co-infected with HIV-1, with meas…
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo) [Phase 1]
Phase 1 pharmacokinetics study of acyclovir in premature infants completed; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia [Phase 3]
Phase 3 trial evaluating acyclovir to prevent herpes simplex virus infection in neutropenic patients has completed with results posted in 20…
-
FDA approval · 2013-10-29FDA Approved: ACYCLOVIR — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' original application for generic acyclovir, used to treat infections caused by herpes simplex virus and…